カテゴリー： QYResearch, 世界

世界の心筋梗塞治療薬市場 2019年

【英語タイトル】Global Myocardial Infarction Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X11786）・商品コード：DATA909X11786
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、心筋梗塞治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、JVS-200、KR-33028、AMRS-001、ANG-4011、Balixafortide、CAP-1002、Cenderitide、その他に、用途別には、研究センター、病院、クリニックにセグメント区分し、心筋梗塞治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・心筋梗塞治療薬の世界市場概要
・心筋梗塞治療薬の製造コスト構成分析
・心筋梗塞治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・心筋梗塞治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・心筋梗塞治療薬のセグメント分析（種類別）
（JVS-200、KR-33028、AMRS-001、ANG-4011、Balixafortide、CAP-1002、Cenderitide、その他）
・心筋梗塞治療薬のセグメント分析（用途別）
（研究センター、病院、クリニック）
・心筋梗塞治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（BioCardia, Inc.、Biscayne Pharmaceuticals, Inc.、Capricor Therapeutics, Inc.、CellProthera、Celyad SA、Compugen Ltd.、CSL Limited、Cynata Therapeutics Limited、FibroGen, Inc.、Hemostemix Ltd、Human Stem Cells Institute、HUYA Bioscience International, LLC、Immune Pharmaceuticals Inc.、Juventas Therapeutics, Inc.、Laboratoires Pierre Fabre SA、Lee's Pharmaceutical Holdings Limited、LegoChem Biosciences, Inc、）
・心筋梗塞治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Myocardial Infarction Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Myocardial Infarction Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myocardial Infarction Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Myocardial Infarction Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Myocardial Infarction Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
BioCardia, Inc.
Biscayne Pharmaceuticals, Inc.
Capricor Therapeutics, Inc.
CellProthera
Celyad SA
Compugen Ltd.
CSL Limited
Cynata Therapeutics Limited
FibroGen, Inc.
Hemostemix Ltd
Human Stem Cells Institute
HUYA Bioscience International, LLC
Immune Pharmaceuticals Inc.
Juventas Therapeutics, Inc.
Laboratoires Pierre Fabre SA
Lee’s Pharmaceutical Holdings Limited
LegoChem Biosciences, Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
JVS-200
KR-33028
AMRS-001
ANG-4011
Balixafortide
CAP-1002
Cenderitide
Others

Segment by Application
Research Center
Hospital
Clinic

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Myocardial Infarction Drug
1.1 Definition of Myocardial Infarction Drug
1.2 Myocardial Infarction Drug Segment by Type
1.2.1 Global Myocardial Infarction Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 JVS-200
1.2.3 KR-33028
1.2.4 AMRS-001
1.2.5 ANG-4011
1.2.6 Balixafortide
1.2.7 CAP-1002
1.2.8 Cenderitide
1.2.9 Others
1.3 Myocardial Infarction Drug Segment by Applications
1.3.1 Global Myocardial Infarction Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Global Myocardial Infarction Drug Overall Market
1.4.1 Global Myocardial Infarction Drug Revenue (2014-2025)
1.4.2 Global Myocardial Infarction Drug Production (2014-2025)
1.4.3 North America Myocardial Infarction Drug Status and Prospect (2014-2025)
1.4.4 Europe Myocardial Infarction Drug Status and Prospect (2014-2025)
1.4.5 China Myocardial Infarction Drug Status and Prospect (2014-2025)
1.4.6 Japan Myocardial Infarction Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Myocardial Infarction Drug Status and Prospect (2014-2025)
1.4.8 India Myocardial Infarction Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Myocardial Infarction Drug
2.3 Manufacturing Process Analysis of Myocardial Infarction Drug
2.4 Industry Chain Structure of Myocardial Infarction Drug

3 Development and Manufacturing Plants Analysis of Myocardial Infarction Drug
3.1 Capacity and Commercial Production Date
3.2 Global Myocardial Infarction Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Myocardial Infarction Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Myocardial Infarction Drug Production and Capacity Analysis
4.2 Myocardial Infarction Drug Revenue Analysis
4.3 Myocardial Infarction Drug Price Analysis
4.4 Market Concentration Degree

5 Myocardial Infarction Drug Regional Market Analysis
5.1 Myocardial Infarction Drug Production by Regions
5.1.1 Global Myocardial Infarction Drug Production by Regions
5.1.2 Global Myocardial Infarction Drug Revenue by Regions
5.2 Myocardial Infarction Drug Consumption by Regions
5.3 North America Myocardial Infarction Drug Market Analysis
5.3.1 North America Myocardial Infarction Drug Production
5.3.2 North America Myocardial Infarction Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Myocardial Infarction Drug Import and Export
5.4 Europe Myocardial Infarction Drug Market Analysis
5.4.1 Europe Myocardial Infarction Drug Production
5.4.2 Europe Myocardial Infarction Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Myocardial Infarction Drug Import and Export
5.5 China Myocardial Infarction Drug Market Analysis
5.5.1 China Myocardial Infarction Drug Production
5.5.2 China Myocardial Infarction Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Myocardial Infarction Drug Import and Export
5.6 Japan Myocardial Infarction Drug Market Analysis
5.6.1 Japan Myocardial Infarction Drug Production
5.6.2 Japan Myocardial Infarction Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Myocardial Infarction Drug Import and Export
5.7 Southeast Asia Myocardial Infarction Drug Market Analysis
5.7.1 Southeast Asia Myocardial Infarction Drug Production
5.7.2 Southeast Asia Myocardial Infarction Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Myocardial Infarction Drug Import and Export
5.8 India Myocardial Infarction Drug Market Analysis
5.8.1 India Myocardial Infarction Drug Production
5.8.2 India Myocardial Infarction Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Myocardial Infarction Drug Import and Export

6 Myocardial Infarction Drug Segment Market Analysis (by Type)
6.1 Global Myocardial Infarction Drug Production by Type
6.2 Global Myocardial Infarction Drug Revenue by Type
6.3 Myocardial Infarction Drug Price by Type

7 Myocardial Infarction Drug Segment Market Analysis (by Application)
7.1 Global Myocardial Infarction Drug Consumption by Application
7.2 Global Myocardial Infarction Drug Consumption Market Share by Application (2014-2019)

8 Myocardial Infarction Drug Major Manufacturers Analysis
8.1 BioCardia, Inc.
8.1.1 BioCardia, Inc. Myocardial Infarction Drug Production Sites and Area Served
8.1.2 BioCardia, Inc. Product Introduction, Application and Specification
8.1.3 BioCardia, Inc. Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biscayne Pharmaceuticals, Inc.
8.2.1 Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production Sites and Area Served
8.2.2 Biscayne Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.2.3 Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Capricor Therapeutics, Inc.
8.3.1 Capricor Therapeutics, Inc. Myocardial Infarction Drug Production Sites and Area Served
8.3.2 Capricor Therapeutics, Inc. Product Introduction, Application and Specification
8.3.3 Capricor Therapeutics, Inc. Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 CellProthera
8.4.1 CellProthera Myocardial Infarction Drug Production Sites and Area Served
8.4.2 CellProthera Product Introduction, Application and Specification
8.4.3 CellProthera Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Celyad SA
8.5.1 Celyad SA Myocardial Infarction Drug Production Sites and Area Served
8.5.2 Celyad SA Product Introduction, Application and Specification
8.5.3 Celyad SA Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Compugen Ltd.
8.6.1 Compugen Ltd. Myocardial Infarction Drug Production Sites and Area Served
8.6.2 Compugen Ltd. Product Introduction, Application and Specification
8.6.3 Compugen Ltd. Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 CSL Limited
8.7.1 CSL Limited Myocardial Infarction Drug Production Sites and Area Served
8.7.2 CSL Limited Product Introduction, Application and Specification
8.7.3 CSL Limited Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Cynata Therapeutics Limited
8.8.1 Cynata Therapeutics Limited Myocardial Infarction Drug Production Sites and Area Served
8.8.2 Cynata Therapeutics Limited Product Introduction, Application and Specification
8.8.3 Cynata Therapeutics Limited Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 FibroGen, Inc.
8.9.1 FibroGen, Inc. Myocardial Infarction Drug Production Sites and Area Served
8.9.2 FibroGen, Inc. Product Introduction, Application and Specification
8.9.3 FibroGen, Inc. Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Hemostemix Ltd
8.10.1 Hemostemix Ltd Myocardial Infarction Drug Production Sites and Area Served
8.10.2 Hemostemix Ltd Product Introduction, Application and Specification
8.10.3 Hemostemix Ltd Myocardial Infarction Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Human Stem Cells Institute
8.12 HUYA Bioscience International, LLC
8.13 Immune Pharmaceuticals Inc.
8.14 Juventas Therapeutics, Inc.
8.15 Laboratoires Pierre Fabre SA
8.16 Lee’s Pharmaceutical Holdings Limited
8.17 LegoChem Biosciences, Inc

9 Development Trend of Analysis of Myocardial Infarction Drug Market
9.1 Global Myocardial Infarction Drug Market Trend Analysis
9.1.1 Global Myocardial Infarction Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Myocardial Infarction Drug Regional Market Trend
9.2.1 North America Myocardial Infarction Drug Forecast 2019-2025
9.2.2 Europe Myocardial Infarction Drug Forecast 2019-2025
9.2.3 China Myocardial Infarction Drug Forecast 2019-2025
9.2.4 Japan Myocardial Infarction Drug Forecast 2019-2025
9.2.5 Southeast Asia Myocardial Infarction Drug Forecast 2019-2025
9.2.6 India Myocardial Infarction Drug Forecast 2019-2025
9.3 Myocardial Infarction Drug Market Trend (Product Type)
9.4 Myocardial Infarction Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Myocardial Infarction Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Myocardial Infarction Drug
Table Global Myocardial Infarction Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Myocardial Infarction Drug Production Market Share by Types in 2018
Figure JVS-200 Product Picture
Figure KR-33028 Product Picture
Figure AMRS-001 Product Picture
Figure ANG-4011 Product Picture
Figure Balixafortide Product Picture
Figure CAP-1002 Product Picture
Figure Cenderitide Product Picture
Figure Others Product Picture
Table Global Myocardial Infarction Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Myocardial Infarction Drug Consumption Market Share by Applications in 2018
Figure Research Center
Figure Hospital
Figure Clinic
Figure Global Myocardial Infarction Drug Revenue (Million USD) (2014-2025)
Figure Global Myocardial Infarction Drug Production (K Pcs) (2014-2025)
Figure North America Myocardial Infarction Drug Market Size (Million USD) (2014-2025)
Figure Europe Myocardial Infarction Drug Market Size (Million USD) (2014-2025)
Figure China Myocardial Infarction Drug Market Size (Million USD) (2014-2025)
Figure Japan Myocardial Infarction Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Myocardial Infarction Drug Market Size (Million USD) (2014-2025)
Figure India Myocardial Infarction Drug Market Size (Million USD) (2014-2025)
Table Myocardial Infarction Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Myocardial Infarction Drug in 2018
Figure Manufacturing Process Analysis of Myocardial Infarction Drug
Figure Industry Chain Structure of Myocardial Infarction Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Myocardial Infarction Drug Manufacturing Plants Distribution
Table Myocardial Infarction Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Myocardial Infarction Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Myocardial Infarction Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Myocardial Infarction Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Myocardial Infarction Drug Production Share by Manufacturers in 2018
Table Myocardial Infarction Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Myocardial Infarction Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Myocardial Infarction Drug Revenue Share by Manufacturers in 2018
Table Myocardial Infarction Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Myocardial Infarction Drug Production by Regions 2014-2019 (K Pcs)
Table Global Myocardial Infarction Drug Production Market Share by Regions 2014-2019
Figure Global Myocardial Infarction Drug Production Market Share by Regions in 2018
Table Global Myocardial Infarction Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Myocardial Infarction Drug Revenue Market Share by Regions 2014-2019
Figure Global Myocardial Infarction Drug Revenue Market Share by Regions in 2018
Table Global Myocardial Infarction Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Myocardial Infarction Drug Consumption Market Share by Regions 2014-2019
Figure North America Myocardial Infarction Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Myocardial Infarction Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Myocardial Infarction Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Myocardial Infarction Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Myocardial Infarction Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Myocardial Infarction Drug Production, Consumption Import and Export (K Pcs)
Figure China Myocardial Infarction Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Myocardial Infarction Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Myocardial Infarction Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Myocardial Infarction Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Myocardial Infarction Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Myocardial Infarction Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Myocardial Infarction Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Myocardial Infarction Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Myocardial Infarction Drug Production, Consumption Import and Export (K Pcs)
Figure India Myocardial Infarction Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Myocardial Infarction Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Myocardial Infarction Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Myocardial Infarction Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Myocardial Infarction Drug Market Share by Application (2014-2019)
Table BioCardia, Inc. Myocardial Infarction Drug Production Sites and Area Served
Table BioCardia, Inc. Myocardial Infarction Drug Product Introduction, Application and Specification
Table BioCardia, Inc. Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioCardia, Inc. Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table BioCardia, Inc. Myocardial Infarction Drug Production Market Share (2014-2019)
Figure BioCardia, Inc. Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table BioCardia, Inc. Myocardial Infarction Drug Main Business and Markets Served
Table Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production Sites and Area Served
Table Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Product Introduction, Application and Specification
Table Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production Market Share (2014-2019)
Figure Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Main Business and Markets Served
Table Capricor Therapeutics, Inc. Myocardial Infarction Drug Production Sites and Area Served
Table Capricor Therapeutics, Inc. Myocardial Infarction Drug Product Introduction, Application and Specification
Table Capricor Therapeutics, Inc. Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Capricor Therapeutics, Inc. Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table Capricor Therapeutics, Inc. Myocardial Infarction Drug Production Market Share (2014-2019)
Figure Capricor Therapeutics, Inc. Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table Capricor Therapeutics, Inc. Myocardial Infarction Drug Main Business and Markets Served
Table CellProthera Myocardial Infarction Drug Production Sites and Area Served
Table CellProthera Myocardial Infarction Drug Product Introduction, Application and Specification
Table CellProthera Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CellProthera Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table CellProthera Myocardial Infarction Drug Production Market Share (2014-2019)
Figure CellProthera Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table CellProthera Myocardial Infarction Drug Main Business and Markets Served
Table Celyad SA Myocardial Infarction Drug Production Sites and Area Served
Table Celyad SA Myocardial Infarction Drug Product Introduction, Application and Specification
Table Celyad SA Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celyad SA Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table Celyad SA Myocardial Infarction Drug Production Market Share (2014-2019)
Figure Celyad SA Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table Celyad SA Myocardial Infarction Drug Main Business and Markets Served
Table Compugen Ltd. Myocardial Infarction Drug Production Sites and Area Served
Table Compugen Ltd. Myocardial Infarction Drug Product Introduction, Application and Specification
Table Compugen Ltd. Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Compugen Ltd. Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table Compugen Ltd. Myocardial Infarction Drug Production Market Share (2014-2019)
Figure Compugen Ltd. Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table Compugen Ltd. Myocardial Infarction Drug Main Business and Markets Served
Table CSL Limited Myocardial Infarction Drug Production Sites and Area Served
Table CSL Limited Myocardial Infarction Drug Product Introduction, Application and Specification
Table CSL Limited Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CSL Limited Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table CSL Limited Myocardial Infarction Drug Production Market Share (2014-2019)
Figure CSL Limited Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table CSL Limited Myocardial Infarction Drug Main Business and Markets Served
Table Cynata Therapeutics Limited Myocardial Infarction Drug Production Sites and Area Served
Table Cynata Therapeutics Limited Myocardial Infarction Drug Product Introduction, Application and Specification
Table Cynata Therapeutics Limited Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cynata Therapeutics Limited Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table Cynata Therapeutics Limited Myocardial Infarction Drug Production Market Share (2014-2019)
Figure Cynata Therapeutics Limited Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table Cynata Therapeutics Limited Myocardial Infarction Drug Main Business and Markets Served
Table FibroGen, Inc. Myocardial Infarction Drug Production Sites and Area Served
Table FibroGen, Inc. Myocardial Infarction Drug Product Introduction, Application and Specification
Table FibroGen, Inc. Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table FibroGen, Inc. Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table FibroGen, Inc. Myocardial Infarction Drug Production Market Share (2014-2019)
Figure FibroGen, Inc. Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table FibroGen, Inc. Myocardial Infarction Drug Main Business and Markets Served
Table Hemostemix Ltd Myocardial Infarction Drug Production Sites and Area Served
Table Hemostemix Ltd Myocardial Infarction Drug Product Introduction, Application and Specification
Table Hemostemix Ltd Myocardial Infarction Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hemostemix Ltd Myocardial Infarction Drug Production Growth Rate (2014-2019)
Table Hemostemix Ltd Myocardial Infarction Drug Production Market Share (2014-2019)
Figure Hemostemix Ltd Myocardial Infarction Drug Revenue Market Share (2014-2019)
Table Hemostemix Ltd Myocardial Infarction Drug Main Business and Markets Served
Table Human Stem Cells Institute Myocardial Infarction Drug Production Sites and Area Served
Table HUYA Bioscience International, LLC Myocardial Infarction Drug Production Sites and Area Served
Table Immune Pharmaceuticals Inc. Myocardial Infarction Drug Production Sites and Area Served
Table Juventas Therapeutics, Inc. Myocardial Infarction Drug Production Sites and Area Served
Table Laboratoires Pierre Fabre SA Myocardial Infarction Drug Production Sites and Area Served
Table Lee's Pharmaceutical Holdings Limited Myocardial Infarction Drug Production Sites and Area Served
Table LegoChem Biosciences, Inc Myocardial Infarction Drug Production Sites and Area Served
Figure Global Myocardial Infarction Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Myocardial Infarction Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Myocardial Infarction Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Myocardial Infarction Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Myocardial Infarction Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Myocardial Infarction Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Myocardial Infarction Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Myocardial Infarction Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Myocardial Infarction Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Myocardial Infarction Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Myocardial Infarction Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Myocardial Infarction Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Myocardial Infarction Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Myocardial Infarction Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Myocardial Infarction Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Myocardial Infarction Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Myocardial Infarction Drug by Application (2019-2025)
Table Myocardial Infarction Drug Distributors List
Table Myocardial Infarction Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

BioCardia, Inc.、Biscayne Pharmaceuticals, Inc.、Capricor Therapeutics, Inc.、CellProthera、Celyad SA、Compugen Ltd.、CSL Limited、Cynata Therapeutics Limited、FibroGen, Inc.、Hemostemix Ltd、Human Stem Cells Institute、HUYA Bioscience International, LLC、Immune Pharmaceuticals Inc.、Juventas Therapeutics, Inc.、Laboratoires Pierre Fabre SA、Lee's Pharmaceutical Holdings Limited、LegoChem Biosciences, Inc、

★調査レポート[世界の心筋梗塞治療薬市場 2019年] (コード：DATA909X11786)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の心筋梗塞治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の心筋梗塞治療法市場 2019年
    DATA909X11787 / QYResearch / 2019年11月20日 / ※本調査レポートは、心筋梗塞治療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、鎮痛薬、抗血小板薬、血管拡張薬、血栓溶解薬および抗血栓薬、糖タンパク質IIb / IIIa阻害薬、Βアドレナリン遮断薬、その他に、用途別には、病院、病院薬局、ドラッグストア、オンラインドラッグストアにセグメント区分し、心筋梗塞治療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・心筋梗塞治療法の世界市場概要 ・心筋梗塞治療法の製造コスト構成分析 ・心筋梗塞治療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・心筋梗塞治療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド）...The global Myocardial Infarction Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myocardial Infarction Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myocardial Infarction Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Myocardial Infarction Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の心筋虚血治療薬市場 2019年
    DATA909X11788 / QYResearch / 2019年11月20日 / ※本調査レポートは、心筋虚血治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BAY-606583、CMK-103、DT-010、フマニン、その他に、用途別には、病院、クリニック、その他にセグメント区分し、心筋虚血治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・心筋虚血治療薬の世界市場概要 ・心筋虚血治療薬の製造コスト構成分析 ・心筋虚血治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・心筋虚血治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・心筋虚血治療薬のセグメント分析（種類別） （BAY-606583、CMK-103、DT-010、フマニン、その他）...The global Myocardial Ischemia Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myocardial Ischemia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myocardial Ischemia Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Myocardial Ischemia Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の心筋血行再建・修復・再生製品・療法市場 2019年
    DATA909X11789 / QYResearch / 2019年11月20日 / ※本調査レポートは、心筋血行再建・修復・再生製品・療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、心筋血行再建技術、アテローム性動脈硬化管理技術、急流および新興の心筋修復/再生技術に、用途別には、病院、看護センター、その他にセグメント区分し、心筋血行再建・修復・再生製品・療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・心筋血行再建・修復・再生製品・療法の世界市場概要 ・心筋血行再建・修復・再生製品・療法の製造コスト構成分析 ・心筋血行再建・修復・再生製品・療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・心筋血行再建・修復・再生製品・療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・心筋血行再建・修復・再生製品・療法のセグメント分析（種類別） （心筋血行再建技術、アテローム性動脈硬化管理技術、急流および新興の心筋修復/再生技術）...The global Myocardial Revascularization, Repair, and Regeneration Products and Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myocardial Revascularization, Repair, and Regeneration Products and Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myocardial Revascularization, Repair, and Regeneration Products and Therapies market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Myocardial Revascularization, Repair, and Regeneration...
  • 脳梗塞治療の世界市場：規模・現状・予測2019-2025
    DATA909X18269 / QYResearch / 2019年11月25日 / ※当調査レポートでは、脳梗塞治療の世界市場について調査・分析し、脳梗塞治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（部分的前部循環梗塞（PACI）、総前部循環梗塞（TACI）、後部循環梗塞（POCI））、用途別（病院、診療所、医学研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の脳梗塞治療市場動向 ・主要企業別マーケットシェア ・脳梗塞治療の種類別市場規模2014-2019 （部分的前部循環梗塞（PACI）、総前部循環梗塞（TACI）、後部循環梗塞（POCI）） ・脳梗塞治療の用途別市場規模2014-2019 （病院、診療所、医学研究機関） ・脳梗塞治療の北米市場：主要企業・種類別/用途別市場規模 ・脳梗塞治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Cerebral infarction is a chronic and life-threatening disease.Cerebral infarction is one of the most important types of ischemic stroke in which blood enters the brain due to the development of blockages or clots in blood vessels.It is important to emphasize that cerebral infarction is different from cerebral hemorrhage.The chance of death is high because of the sudden onset of the disease.In 2018, the global Cerebral Infarction Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆